COVID-19 tools and resources: symptom checker, safety measures, and visitor, testing and vaccine info. Learn more.
COVID-19 tools and resources: symptom checker, safety measures, and visitor, testing and vaccine info. Learn more.
CONDITION(S): Acute Myeloid Leukemia (AML) - TRIAL: Tolero Pharmaceuticals, Inc. TPI-ALV-202 - Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
This study will evaluate the safety and efficacy of alvocidib in patients with AML who have either relapsed from or are refractory to venetoclax in combination with azacytidine or decitabine.